Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.41 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.38 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.38 |
| ▸ | NTRK2 | Q16620 | 1/20 | 0.37 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.36 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.36 |
| ▸ | REN | P00797 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 2/20 | 0.32 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | CA9 | Q16790 | 2/20 | 0.32 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.31 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.31 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.31 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.31 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.31 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.31 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9230251 | 0.95 | GPR84 (0.40) | CAMK2AGPR84FFAR1FFAR4NTRK2 | |
| SCHEMBL6247927 | 0.95 | CAMK2A (0.38) | CAMK2AGPR84FFAR1FFAR4NTRK2 | |
| SCHEMBL11595248 | 0.89 | CAMK2A (0.38) | CAMK2AGPR84FFAR1FFAR4NTRK2 | |
| SCHEMBL6142653 | 0.88 | CA12 (0.43) | CAMK2ANTRK2CA12CA1CA9 | |
| SCHEMBL6246329 | 0.87 | GPR84 (0.39) | CAMK2AGPR84FFAR1FFAR4NTRK2 | |
| SCHEMBL20876137 | 0.85 | CA12 (0.43) | CAMK2AGPR84NTRK2HDAC1HDAC6 | |
| SCHEMBL6883197 | 0.83 | CA12 (0.35) | CAMK2AGPR84FFAR1FFAR4REN | |
| SCHEMBL17841944 | 0.82 | NTRK2 (0.33) | CAMK2ANTRK2HDAC1HDAC6 | |
| SCHEMBL2493116 | 0.81 | CA12 (0.41) | CAMK2AHDAC1HDAC6CA12CA1 | |
| SCHEMBL23120358 | 0.79 | ALOX5 (0.53) | HDAC1HDAC6RENHDAC3HDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0797611-B1 | ACID ETCH RESISTANT AUTOMOTIVE TOPCOAT | KING INDUSTRIES INC (US) | 1999-01-27 | — | — | EP | claimed |
| US-11084779-B2 | Cationic lipids for therapeutic agent delivery formulations | NITTO DENKO CORPORATION (JP) | 2021-08-10 | — | — | US | disclosed |
| US-10961181-B2 | — | — | 2021-03-30 | — | — | US | disclosed |
| US-20200199064-A1 | CATIONIC LIPIDS FOR THERAPEUTIC AGENT DELIVERY FORMULATIONS | NITTO DENKO CORPORATION (JP) | 2020-06-25 | — | — | US | disclosed |
| EP-2998289-B1 | COMPOUNDS FOR TARGETING DRUG DELIVERY AND ENHANCING SIRNA ACTIVITY | NITTO DENKO CORP (JP) | 2019-08-07 | — | — | EP | disclosed |
| US-10196637-B2 | Retinoid-lipid drug carrier | NITTO DENKO CORPORATION (JP) | 2019-02-05 | — | — | US | disclosed |
| US-20180208547-A1 | CATIONIC LIPIDS FOR THERAPEUTIC AGENT DELIVERY FORMULATIONS | NITTO DENKO CORPORATION (JP) | 2018-07-26 | — | — | US | disclosed |
| US-9963424-B2 | Cationic lipids for therapeutic agent delivery formulations | NITTO DENKO CORPORATION (JP) | 2018-05-08 | — | — | US | disclosed |
| US-20170081663-A1 | RETINOID-LIPID DRUG CARRIER | NITTO DENKO CORPORATION (JP) | 2017-03-23 | — | — | US | disclosed |
| US-20160137593-A1 | Cationic Lipids for Therapeutic Agent Delivery Formulations | NITTO DENKO CORP (JP) | 2016-05-19 | — | — | US | disclosed |
| EP-1021245-A4 | NOVEL ZIRCONIUM URETHANE CATALYSTS | KING INDUSTRIES INC (US) | 2001-11-14 | — | — | EP | disclosed |
| EP-1021245-A1 | NOVEL ZIRCONIUM URETHANE CATALYSTS | KING INDUSTRIES, INC. (US) | 2000-07-26 | — | — | EP | disclosed |
| EP-0797611-B1 | ACID ETCH RESISTANT AUTOMOTIVE TOPCOAT | KING INDUSTRIES INC (US) | 1999-01-27 | — | — | EP | disclosed |
| WO-1998041322-A1 | NOVEL ZIRCONIUM URETHANE CATALYSTS | KING INDUSTRIES, INC. (US) | 1998-09-24 | — | — | WO | disclosed |
| EP-0797611-A1 | ACID ETCH RESISTANT AUTOMOTIVE TOPCOAT | Blank, Werner J. (US) | 1997-10-01 | — | — | EP | disclosed |
| US-5565531-A | AUTOMOBILE PROTECTIVE TOPCOATINGS COMPRISING POLYURETHANES HAVING PENDANT ALKYL CHAINS CONTAINING AN ETHER MADE FROM A DICARBAMATE, POLYOL AND ETHER-CONTAINING CARBAMATE; WEATHERPROOFING; DURABILITY; SOLVENT SOLUBILITY | KING INDUSTRIES, INC. (US) | 1996-10-15 | — | — | US | disclosed |
| WO-1995032999-A1 | ACID ETCH RESISTANT AUTOMOTIVE TOPCOAT | BLANK WERNER J (US) | 1995-12-07 | — | — | WO | disclosed |
| US-5336704-A | Within hydrogel chelation polymer using precipitative anion; safe disposal of toxic metals | RAINER NORMAN B (US) | 1994-08-09 | — | — | US | disclosed |
| EP-0204234-A2 | Use of polyesters with sulfonic acid groups | Henkel Kommanditgesellschaft auf Aktien (DE) | 1986-12-10 | — | — | EP | disclosed |
| US-4472165-A | UREA-FORMALDEHYDE RESIN, WRINKLE RESISTANCE, FOAMING, SCAVENGERS, COLLAPSING, CURING | UNITED MERCHANTS AND MANUFACTURERS, INC. (US) | 1984-09-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160137593-A1 | Cationic Lipids for Therapeutic Agent Delivery Formulations | SGMS1, SGMS2, CERT1 | CAMK2A 4568/4885GPR84 872/4885FFAR1 194/4885 |
| US-20180208547-A1 | CATIONIC LIPIDS FOR THERAPEUTIC AGENT DELIVERY FORMULATIONS | SGMS1, SGMS2, S1PR1 | CAMK2A 4204/4885GPR84 836/4885FFAR1 230/4885 |
| US-20200199064-A1 | CATIONIC LIPIDS FOR THERAPEUTIC AGENT DELIVERY FORMULATIONS | SGMS1, SGMS2, CERT1 | CAMK2A 4565/4885GPR84 721/4885FFAR1 177/4885 |
| US-20170081663-A1 | RETINOID-LIPID DRUG CARRIER | RXRA, RXRG, LRAT | CAMK2A 3677/4885GPR84 812/4885FFAR1 869/4885 |
| US-10961181-B2 | — | DEGS1, SGMS1, C5 | CAMK2A 4422/4885GPR84 501/4885FFAR1 212/4885 |
| US-11084779-B2 | Cationic lipids for therapeutic agent delivery formulations | SGMS1, SGMS2, CERT1 | CAMK2A 4565/4885GPR84 721/4885FFAR1 177/4885 |
| US-10196637-B2 | Retinoid-lipid drug carrier | RXRA, RXRG, LRAT | CAMK2A 3677/4885GPR84 812/4885FFAR1 869/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.